95,96 Pharmacological agents such as GLP-1 RAs mimic endogenous GLP-1 regulatory activities, aiding in T2D management by increasing the incretin effect, postprandial insulin release, increased satiety, and decreased glucagon secretion, thus improving glycemic control
That means: 1 unit = 0.01 mL 10 units = 0.1 mL 50 units = 0.5 mL 100 units = 1.0 mL The "U-100" designation refers to the insulin concentration the syringe was designed for, not anything about peptides
Your GLP-1 exposure has been low, so standard onboarding applies
All compounds discussed are supplied strictly for in vitro laboratory and preclinical research by qualified personnel, and are not for human consumption, therapeutic use, cosmetic use, or veterinary application